Patents by Inventor Pierre-Oliver LAVOIE

Pierre-Oliver LAVOIE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210246462
    Abstract: An isolated expression enhancer active in a plant, portion of a plant or plant cell, the expression enhancer is provided. The isolated expression enhancer may be selected from the group consisting of nbMT78 (SEQ ID NO:1); nbATL75 (SEQ ID NO:2); nbDJ46 (SEQ ID NO:3); nbCHP79 (SEQ ID NO:4); nbEN42 (SEQ ID NO:5); atHSP69 (SEQ ID NO:6); atGRP62 (SEQ ID NO:7); atPK65 (SEQ ID NO:8); atRP46 (SEQ ID NO:9); nb30S72 (SEQ ID NO:10); nbGT61 (SEQ ID NO:11); nbPV55 (SEQ ID NO:12); nbPPI43 (SEQ ID NO:13); nbPM64 (SEQ ID NO:14); and nbH2A86 (SEQ ID NO:15). Methods for using the isolated expression enhancer are also provided.
    Type: Application
    Filed: March 14, 2019
    Publication date: August 12, 2021
    Applicants: Medicago Inc., National University Corporation Nara Institute of Science and Technology, Mitsubishi TanabePhatmaCorporation
    Inventors: Pierre-Oliver LAVOIE, Marc-Andre D'AOUST, Ko KATO, Shotaro YAMASAKI